2m 2m 2m 2m 2m 2m 2m
Agios Pharm (AGIO)
NASDAQ
$33.00-$0.60 (-1.79%)
Price as of Sep 11, 2026 7:30 PM EDT- $2.0BMarket Cap
- -8.65%1-Year Change
- BiotechnologyIndustry
Agios Pharm (AGIO)
$33.00-$0.60 (-1.79%)
AGIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $33.60 | ||
Change | -$0.04 (-0.12%) | ||
Open | $33.94 | ||
High | $34.28 | ||
Low | $33.32 | ||
Previous Close | $33.64 | ||
Volume | 750,171 | ||
30-Day Average Volume | 895,729 | ||
1-Week Change | 1.51% | ||
1-Month Change | 2.78% | ||
1-Year Change | -8.65% | ||
3-Year Change | 25.05% | ||
5-Year Change | -25.63% | ||
Fundamentals | |||
Shares Outstanding | 59.7M | ||
Total Assets | $1.1B | ||
Market Cap | $2.0B | ||
Enterprise Value | $1.9B | ||
Period: QTR TTM FY | |||
Revenue | $44.7M | ||
Net Income | -$100.7M | ||
Free Cash Flow | -$58.5M | ||
EBIT | -$100.7M | ||
EBITDA | -$99.4M | ||
Net Working Capital | $647.5M | ||
EPS | -$1.69 | ||
Enterprise Value/EBITDA | -19 | ||
Enterprise Value/Revenue | 43 | ||
P/B | 2 | ||
P/E | -20 | ||
PEG | N/A | ||
Price/Free Cash Flow | -34 | ||
Price/Operating Cash Flow | -35 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue